Yahoo Finance1mon
Santen, Arctic Vision sign deal for ARVN001 to treat UME
Santen Pharmaceutical and Arctic Vision have signed a commercial collaboration agreement for the ARVN001 suprachoroidal injectable suspension, a treatment for uveitic macular oedema (UME ...
Yahoo Finance6d
Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States
As a result, we hosted three separate sessions to provide demonstrations of our suprachoroidal injection procedure. These sessions enabled attendees to familiarize themselves with our SCS ...
Eagle-Tribune1mon
Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors
I am honored to be named Chair at this important time for the Company as we continue expanding the use of our market-leading suprachoroidal delivery platform on our own and with corporate partners ...
Business Insider1mon
Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
About Clearside Biomedical, Inc. Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ...
manilatimes29d
Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update
Nov. 12, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal ...
Stockhouse17d
Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States
ALPHARETTA, Ga., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...